Announcement

Collapse
No announcement yet.

Emerg Infect Dis. Carbapenemases in Enterobacteria, Hong Kong, China, 2009

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Emerg Infect Dis. Carbapenemases in Enterobacteria, Hong Kong, China, 2009

    Carbapenemases in Enterobacteria, Hong Kong, China, 2009 (Emerg Infect Dis., extract, edited)


    [Source: US Centers for Disease Control and Prevention, Emerging Infectious Diseases Journal, full PDF document, (LINK). Extract, edited.]

    DOI: 10.3201/eid1701.101443

    Suggested citation for this article: Chu Y-W, Tung VWN, Cheung TKM, Chu M-Y, Cheng N, Lai C, et al. Carbapenemases in enterobacteria, Hong Kong, China, 2009 [letter]. Emerg Infect Dis. 2011 Jan; [Epub ahead of print]

    Carbapenemases in Enterobacteria, Hong Kong, China, 2009


    To the Editor:

    Carbapenems are often the recommended treatment for serious infections caused by extended-spectrum β-lactamase?producing enterobacteria. However, enzyme-mediated carbapenem resistance is increasingly reported worldwide. Carbapenemases are represented by 3 molecular classes of β-lactamase: A, B, and D (1). The best known class A carbapenemase is Klebsiella pneumoniae carbapenemase (KPC); KPC-producing enterobacteria are responsible for many hospital outbreaks. Class B carbapenemases are metallo-β-lactamases (MBL), which have the widest substrate spectrum. Class D OXA-type carbapenemases are found mainly in nonfermenting bacteria, except for OXA-48, which has been found only in enterobacteria.

    (...)
    -
    ------
Working...
X